Maria C Freire sold $1.5M of Exelixis (EXEL)

Executed Feb 14 2025, disclosed Feb 19 2025, 5 days later.

Value, as filed

$1.5M

44,114 sh × $34.94

Executed

Feb 14 2025

the trade date, as filed

Disclosed

Feb 19 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MF Maria C Freire Director profile →

Maria C Freire (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $949K of EXEL (20,634 sh × $46.00, as filed), executed May 7.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Maria C Freire in EXEL

EXELSALE Exelixis, Inc. $949K
20,634 sh × $46.00
Exec May 7
Filed May 8 · 5:30 PM ET